Hamed Benghuzzi
Keynote: J Neurol Neurophysiol
Evaluation of devices, drugs, and drug delivery systems (CDS) have been investigated by both in vitro and in vivo
procedures. Ceramic drug delivery systems have shown to be biocompatible, non-toxic and highly acceptable by the
host. The CDS can also reduce handling of animals and facilitate long-term evaluations before conducting clinical trials. To
date, CDS have been used to deliver various biologicals such aldosterone, androstanedione, beta-lactoglobulin, bovine serum
albumin, chymotrypsin, danazol, difluoromeythylornithine, dihydrotestosterone, estradiol, gamma globulin, gonadotrophic
releasing hormone, gossypol, growth hormone, insulin, pepsin, progesterone, neuropeptide Y antagonist, thymoquinone,
vitamins and testosterone to name a few . The results of our findings provided significant scientific evidence to effectively
use CDS as an alternative route of drug administration to treat diseases requiring long-term chronic drug therapy as well as
disorders caused by deficiency of certain medications (hormone replacement therapy).
Hamed Benghuzzi is currently the Professor and Chairman at university of Mississippi medical center, USA. His area of research is the development and
applications of novel ceramic drug delivery systems (over 26 years/over 250 publications and 600 abstracts at various meeting). He was fortunate to be recognized
as a fellow by the American Institute of Medical and Biological Engineering, as well as, International Fellow by the World Congress of Biomaterials Societies
(Japanese, American, Asian, and European). His passion is teaching and training students. He had been the mentor of several faculty at the school of health
related professions and other clinical departments including two orthopedic surgery faculty through grants supported by OTA and OREF. He served and serving as
a major advisor for over 30 PhD students as well as a mentor for students at various levels (High school, undergraduate, MS, residents and postdoctoral). He is
also a course director for several graduate and undergraduate courses. These include Pathophysiology (I and II), Histopathology, Pathophysiological phenomena,
Human Physiology and Pathology. Administratively; he served as a chair for departments of Health Sciences, Cytotechnology and currently he serve as a chair of
the Department of Diagnostic and Clinical health sciences and Director of CHS program.
